Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04250337 |
|---|---|
| Brief Title: | Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis. (ADhere) |
| First Submitted : | January 30, 2020 |
| First Submitted that Met QC Criteria : | January 30, 2020 |
| First Posted : | January 31, 2020 |
| Results First Submitted : | March 14, 2022 |
| Results First Submitted that Met QC Criteria : | April 4, 2022 |
| Results First Posted : | May 2, 2022 |
| Last Update Submitted that Met QC Criteria : | May 5, 2022 |
| Last Update Posted : | May 9, 2022 |